Role of central calcitonin gene-related peptide (CGRP) in locomotor and anxiety-and depression-like behaviors in two mouse strains exhibiting a CGRP-dependent difference in thermal pain sensitivity

Journal of Molecular Neuroscience

Volumn 39, Issue 1-2, 2009, Pages 125-136

  Schorscher Petcu, Ara ^a   Austin, Jean Sébastien ^b   Mogil, Jeffrey S ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

Anxiety; CGRP; Depression; Locomotion; Supraspinal; Thermal pain sensitivity

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONIST; CALCITONIN GENE RELATED PEPTIDE[8-37]; OLCEGEPANT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DEPRESSION; DNA POLYMORPHISM; HEAT SENSITIVITY; LOCOMOTION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PROTEIN LOCALIZATION; STRAIN DIFFERENCE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CALCITONIN GENE-RELATED PEPTIDE; DEPRESSION; HOT TEMPERATURE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PAIN; PAIN MEASUREMENT; POLYMORPHISM, GENETIC; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE;

MUS;

EID: 74149092704     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9201-z     Document Type: Article

References (61)

1. Avila, G., Aguilar, C. I., & Ramos-Mondragon, R. (2007). Sustained CGRP1 receptor stimulation modulates development of EC coupling by cAMP/PKA signalling pathway in mouse skeletal myotubes. Journal of Physiology, 584, 47-57. doi:10.1113/jphysiol.2007.137687.
2. Bird, G. C., Han, J. S., Fu, Y., Adwanikar, H., Willis, W. D., Jr., & Neugebauer, V. (2006). Pain-related synaptic plasticity in spinal dorsal horn neurons: Role of CGRP. Molecular Pain, 2, 31-42. doi:10.1186/1744-8069-2- 31.
3. Bouwknecht, J. A., & Paylor, R. (2002). Behavioral and physiological mouse assays for anxiety: A survey in nine mouse strains. Behavioural Brain Research, 136, 489-501. doi:10.1016/S0166-4328 (02) 00200-0.
4. Brain, S. D., & Grant, A. D. (2004). Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiological Reviews, 84, 903-934. doi:10.1152/physrev. 00037.2003.
5. Brown, M. R., & Gray, T. S. (1988). Peptide injections into the amygdala of conscious rats: Effects on blood pressure, heart rate and plasma catecholamines. Regulatory Peptides, 21, 95-106. doi:10.1016/0167-0115 (88) 90094-8.
6. Callahan, B. L., Gil, A. S., Levesque, A., & Mogil, J. S. (2008). Modulation of mechanical and thermal nociceptive sensitivity in the laboratory mouse by behavioral state. Journal of Pain, 9, 174-184. doi:10.1016/j.jpain. 2007.10.011.
7. Calvino, B., & Grilo, R. M. (2006). Central pain control. Joint, Bone, Spine, 73, 10-16. doi:10.1016/j.jbspin. 2004.11.006.
8. Clementi, G., Grassi, M., Valerio, C., Prato, A., Fiore, C. E., & Drago, F. (1992). Effects of calcitonin gene-related peptide on extrapyramidal motor system. Pharmacology, Biochemistry and Behavior, 42, 545-548. doi:10.1016/0091-3057 (92) 90153-7.
9. Cridland, R. A., & Henry, J. L. (1989). Intrathecal administration of CGRP in the rat attenuates a facilitation of the tail flick reflex induced by either substance P or noxious cutaneous stimulation. Neuroscience Letters, 102, 241-246. doi:10.1016/0304-3940 (89) 90085-2.
10. Danaher, R. N., Loomes, K. M., Leonard, B. L., et al. (2008). Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization. Endocrinology, 149, 154-160. doi:10.1210/en. 2007-0583.
11. Dennis, T., Fournier, A., Guard, S., St Pierre, S., & Quirion, R. (1991). Calcitonin gene-related peptide (hCGRP alpha) binding sites in the nucleus accumbens. Atypical structural requirements and marked phylogenic differences. Brain Research, 539, 59-66. doi:10.1016/0006-8993 (91) 90686-P.
12. Deutch, A. Y., & Roth, R. H. (1987). Calcitonin gene-related peptide in the ventral tegmental area: Selective modulation of prefrontal cortical dopamine metabolism. Neuroscience Letters, 74, 169-174. doi:10.1016/0304-3940 (87) 90144-3.
13. Dobolyi, A., Irwin, S., Makara, G., Usdin, T. B., & Palkovits, M. (2005). Calcitonin gene-related peptide-containing pathways in the rat forebrain. Journal of Comparative Neurology, 489, 92-119. doi:10.1002/cne.20618.
14. Doods, H., Hallermayer, G., Wu, D., et al. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. British Journal of Pharmacology, 129, 420-423. doi:10.1038/sj.bjp. 0703110.
15. Drumheller, A., Menard, D., Fournier, A., & Jolicoeur, F. B. (1992). Neurochemical effects of CGRP. Annals of the New York Academy of Sciences, 657, 546-548. doi:10.1111/j.1749-6632. 1992.tb22830.x.
16. Evans, B. N., Rosenblatt, M. I., Mnayer, L. O., Oliver, K. R., & Dickerson, I. M. (2000). CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors. Journal of Biological Chemistry, 275, 31438-31443. doi:10.1074/jbc. M005604200.
17. Fernandez, H. L., Chen, M., Nadelhaft, I., & Durr, J. A. (2003). Calcitonin gene-related peptides: Their binding sites and receptor accessory proteins in adult mammalian skeletal muscles. Neuroscience, 119, 335-345. doi:10.1016/S0306-4522 (03) 00163-5.
18. Gebhart, G. F. (2004). Descending modulation of pain. Neuroscience and Biobehavioral Reviews, 27, 729-737. doi:10.1016/j. neubiorev. 2003.11.008.
19. Gregg, K. V., Bishop, G. A., & King, J. S. (1999). Fine structural analysis of calcitonin gene-related peptide in the mouse inferior olivary complex. Journal of Neurocytology, 28, 431-438. doi:10.1023/A: 1007032119792.
20. Han, J. S., Li, W., & Neugebauer, V. (2005). Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. Journal of Neuroscience, 25, 10717-10728. doi:10.1523/JNEUROSCI.4112-05.2005.
21. Hogg, S. (1996). A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology, Biochemistry and Behavior, 54, 21-30. doi:10.1016/0091-3057 (95) 02126-4.
22. Hokfelt, T., Arvidsson, U., Ceccatelli, S., et al. (1992). Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems. Annals of the New York Academy of Sciences, 657, 119-134. doi:10.1111/j.1749-6632.1992.tb22762.x.
23. Huang, Y., Brodda-Jansen, G., Lundeberg, T., & Yu, L. C. (2000). Antinociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: An effect attenuated by naloxone. Brain Research, 873, 54-59. doi:10.1016/S0006-8993 (00) 02473-2.
24. Iovino, M., Feifel, U., Yong, C. L., Wolters, J. M., & Wallenstein, G. (2004). Safety, tolerability and pharmacokinetics of BIBN 4096 BS, the first selective small molecule calcitonin gene-related peptide receptor antagonist, following single intravenous administration in healthy volunteers. Cephalalgia, 24, 645-656. doi:10.1111/j.1468-2982.2004.00726.x.
25. Jacques, D., Dumont, Y., Van Rossum, D., & Quirion, R. (2000). Calcitonin gene-related peptide (CGRP), amylin and adrenomedullin: Anatomical localization and biological functions in the mammalian and human brains. In R. Quirion, A. Björklund & T. Hökfeld (Eds.), Peptide receptors, part 1. Handbook of chemical neuroanatomy, Vol. 16, pp. 301-374. London: Elsevier.
26. Juaneda, C., Dumont, Y., & Quirion, R. (2000). The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends in Pharmacological Sciences, 21, 432-438. doi:10.1016/S0165-6147 (00) 01555-8.
27. Kawai, Y., Takami, K., Shiosaka, S., et al. (1985). Topographic localization of calcitonin gene-related peptide in the rat brain: An immunohistochemical analysis. Neuroscience, 15, 747-763. doi:10.1016/0306-4522 (85) 90076-4.
28. Kocorowski, L. H., & Helmstetter, F. J. (2001). Calcitonin generelated peptide released within the amygdala is involved in Pavlovian auditory fear conditioning. Neurobiology of Learning and Memory, 75, 149-163. doi:10.1006/nlme.2000.3963.
29. Kovacs, A., & Telegdy, G. (1994). CGRP prevents electroconvulsive shock-induced amnesia in rats. Pharmacology, Biochemistry and Behavior, 47, 121-125. doi:10.1016/0091-3057 (94) 90120-1.
30. Kovacs, A., & Telegdy, G. (1995). Effects of CGRP on active avoidance behavior in rats. Physiology & Behavior, 58, 429-435. doi:10.1016/0031-9384 (95) 00066-R.
31. Kovacs, A., Telegdy, G., Toth, G., & Penke, B. (1999). Neurotransmittermediated open-field behavioral action of CGRP. Life Sciences, 64, 733-740. doi:10.1016/S0024-3205 (99) 00002-8.
32. Kresse, A., Jacobowitz, D. M., & Skofitsch, G. (1995). Detailed mapping of CGRP mRNA expression in the rat central nervous system: Comparison with previous immunocytochemical findings. Brain Research Bulletin, 36, 261-274. doi:10.1016/0361-9230 (94) 00201-B.
33. Kuraishi, Y., Nanayama, T., Ohno, H., et al. (1989). Calcitonin generelated peptide increases in the dorsal root ganglia of adjuvant arthritic rat. Peptides, 10, 447-452. doi:10.1016/0196-9781 (89) 90057-0.
34. Langford, D. J., Crager, S. E., Shehzad, Z., et al. (2006). Social modulation of pain as evidence for empathy in mice. Science, 312, 1967-1970. doi:10.1126/science.1128322.
35. Laursen, S. E., & Belknap, J. K. (1986). Intracerebroventricular injections in mice. Some methodological refinements. Journal of Pharmacological Methods, 16, 355-357. doi:10.1016/0160-5402 (86) 90038-0.
36. Li, N., Lundeberg, T., & Yu, L. C. (2001). Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats. Brain Research, 901, 161-166. doi:10.1016/S0006-8993 (01) 02341-1.
37. Martinowich, K., Manji, H., & Lu, B. (2007). New insights into BDNF function in depression and anxiety. Nature Neuroscience, 10, 1089-1093. doi:10.1038/nn1971.
38. Mata, J., Marguerat, S., & Bahler, J. (2005). Post-transcriptional control of gene expression: A genome-wide perspective. Trends in Biochemical Sciences, 30, 506-514. doi:10.1016/j.tibs.2005. 07.005.
39. Mathe, A. A., Agren, H., Lindstrom, L., & Theodorsson, E. (1994). Increased concentration of calcitonin gene-related peptide in cerebrospinal fluid of depressed patients. A possible trait marker of major depressive disorder. Neuroscience Letters, 182, 138-142. doi:10.1016/0304-3940 (94) 90782-X.
40. Mathe, A. A., Agren, H., Wallin, A., & Blennow, K. (2002). Calcitonin gene-related peptide and calcitonin in the CSF of patients with dementia and depression: Possible disease markers. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 26, 41-48. doi:10.1016/S0278-5846 (01) 00219-6.
41. McLatchie, L. M., Fraser, N. J., Main, M. J., et al. (1998). RAMPs regulate the transport and ligand specificity of the calcitoninreceptor-like receptor. Nature, 393, 333-339. doi:10.1038/30666.
42. Mogil, J. S., Miermeister, F., Seifert, F., et al. (2005). Variable sensitivity to noxious heat is mediated by differential expression of the CGRP gene. Proceedings of the National Academy of Sciences of the United States of America, 102, 12938-12943. doi:10.1073/pnas.0503264102.
43. Nestler, E. J., & Carlezon, W. A., Jr. (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry, 59, 1151-1159. doi:10.1016/j.biopsych.2005.09.018.
44. Olesen, J., Diener, H. C., Husstedt, I. W., et al. (2004). Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. New England Journal of Medicine, 350, 1104-1110. doi:10.1056/NEJMoa030505.
45. Papp, M., Willner, P., & Muscat, R. (1991). An animal model of anhedonia: Attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology, 104, 255-259. doi:10.1007/BF02244188.
46. Peltier, A. C., & Bishop, G. A. (1999). The site of origin of calcitonin gene-related peptide-like immunoreactive afferents to the inferior olivary complex of the mouse. Neuroscience Research, 34, 177-186. doi:10.1016/S0168-0102 (99) 00045-0.
47. Petit-Demouliere, B., Chenu, F., & Bourin, M. (2005). Forced swimming test in mice: A review of antidepressant activity. Psychopharmacology, 177, 245-255. doi:10.1007/s00213-004-2048-7.
48. Poore, L. H., & Helmstetter, F. J. (1996). The effects of central injections of calcitonin gene-related peptide on fear-related behavior. Neurobiology of Learning and Memory, 66, 241-245. doi:10.1006/nlme.1996. 0065.
49. Poyner, D. R., Sexton, P. M., Marshall, I., et al. (2002). International Union of Pharmacology. XXXII. The mammalian calcitonin generelated peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacological Reviews, 54, 233-246. doi:10.1124/pr.54.2.233.
50. Radziszewski, P., Soller, W., & Mattiasson, A. (2003). Calcitonin gene-related peptide and substance P induce pronounced motor effects in the female rat urethra in vivo. Scandinavian Journal of Urology and Nephrology, 37, 275-280. doi:10.1080/00365590310004761.
51. Rosenfeld, M. G., Mermod, J. J., Amara, S. G., et al. (1983). Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature, 304, 129-135. doi: 10.1038/304129a0.
52. Sexton, P. M., McKenzie, J. S., Mason, R. T., Moseley, J. M., Martin, T. J., & Mendelsohn, F. A. (1986). Localization of binding sites for calcitonin gene-related peptide in rat brain by in vitro autoradiography. Neuroscience, 19, 1235-1245. doi:10.1016/0306-4522 (86) 90137-5.
53. Skofitsch, G, & Jacobowitz, D. M. (1985a). Autoradiographic distribution of 125I calcitonin gene-related peptide binding sites in the rat central nervous system. Peptides, 6, 975-986. doi: 10.1016/0196-9781 (85) 90331-6.
54. Skofitsch, G, & Jacobowitz, D. M. (1985b). Calcitonin gene-related peptide: Detailed immunohistochemical distribution in the central nervous system. Peptides, 6, 721-745. doi:10.1016/0196-9781 (85) 90178-0.
55. Sun, R. Q., Lawand, N. B., & Willis, W. D. (2003). The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain, 104, 201-208. doi: 10.1016/S0304-3959 (03) 00008-3.
56. van Rossum, D., Hanisch, U. K., & Quirion, R. (1997). Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neuroscience and Biobehavioral Reviews, 21, 649-678. doi:10.1016/S0149-7634 (96) 00023-1.
57. Wortwein, G, Husum, H., Andersson, W., Bolwig, T. G, & Mathe, A. A. (2006). Effects of maternal separation on neuropeptide Y and calcitonin gene-related peptide in "depressed" Flinders Sensitive Line rats: A study of gene-environment interactions. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 30, 684-693. doi:10.1016/j.pnpbp. 2006.01.027.
58. Xu, W., Lundeberg, T., Wang, Y. T., Li, Y, & Yu, L. C. (2003). Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: Activating opioid receptors through amygdala-periaqueductal gray pathway. Neuroscience, 118, 1015-1022. doi:10.1016/S0306-4522 (03) 00069-1.
59. Yashpal, K., Kar, S., Dennis, T., & Quirion, R. (1992). Quantitative autoradiographic distribution of calcitonin gene-related peptide (hCGRP alpha) binding sites in the rat and monkey spinal cord. Journal of Comparative Neurology, 322, 224-232. doi: 10.1002/cne.903220208.
60. Yu, L. C, Weng, X. H., Wang, J. W., & Lundeberg, T. (2003). Involvement of calcitonin gene-related peptide and its receptor in anti-nociception in the periaqueductal grey of rats. Neuroscience Letters, 349, 1-4. doi:10.1016/S0304-3940 (03) 00273-8.
61. Zhou, X., Li, J. J., & Yu, L. C. (2003). Plastic changes of calcitonin gene-related peptide in morphine tolerance: Behavioral and immunohistochemical study in rats. Journal of Neuroscience Research, 74, 622-629. doi:10.1002/jnr.10770.